プログラム

スペイン、マドリード    2024年4月21日~24日

企画:

主催:

プログラム

2024年WFH世界会議
[email protected]

企画:
世界血友病連盟

主催:
Federación Española de Hemofilia

2024年WFH世界会議では、医学および出血性疾患患者(PWBD)トラックと、看護学、歯科学、実験科学、社会心理学、筋骨格学(MSK)および出血性疾患を抱える女性および女児(WGBD)の6つの専門的能力開発トラックにわたる継続教育セッション(90分間)をご用意しています。全員参加のセッションおよび各セッションでは世界クラスの講演者が登壇することや、対話形式のセッション、ワークショップ、パネルディスカッション、革新的な業界シンポジウムが実施されることもこの会議の特徴です。

CME CREDITS

The WFH 2024 World Congress has been accredited with 32 credits by the European Board for Accreditation in Hematology (EBAH), an accreditation body supported and endorsed by the European Hematology Association (EHA).

Participants should only claim credits for the time actually spent at the World Congress. Participants wishing to collect CME credits will need to check-in and check-out at the start and end of each day for which they wish to claim CME credits.

  • CME Desk located next to the registration desk in the Exhibit Hall
  • CME Desk located on the first floor of the North Convention Center
  • 1 hour of CME-CPD activity = 1 EBAH CME-CPD credit point
  • Maximum of 8.0 EBAH CME credit points per Congress day

Participants will be asked to complete a questionnaire for each day they are claiming credits, in order to confirm their participation in our scientific program.

Log in to your EBAH account (login) or create an EBAH CME account if you do not already have one (create account).

  1. Creating an EBAH CME account or logging in is simple and free of cost.
  2. Please add your EBAH CME account number to your Congress registration profile, so that your EBAH-CME credit points can be added to your account. Click here to access your registration profile.

Within the EBAH-CME system, you can:

  • Print your EBAH-CME certificates.
  • Review and manage your personal account.
  • Search for accredited events based on the European Hematology Curriculum.

SYMPOSIA SCHEDULE

Explore our dynamic symposia schedule, offering a diverse array of engaging topics. All symposia will be held in Exhibit Hall 9.

12:45-13:45

ROOM 1: Takeda

Unleashing the management of patients with hemophilia A with inhibitors – from expert opinion to clinical decision


12:45-13:45

ROOM 2: WFH session – supported by CSL Behring

Living the gene therapy treatment journey (WFH)


12:45-13:45

ROOM 3: Sobi Sanofi

Reaching new heights in hemophilia A: the impact of higher factor levels


18:30-19:30

ROOM 1: Pfizer

New horizons: The value of continued innovation in hemophilia


18:30-19:30

ROOM 2: Hoffmann-La Roche

Dreaming the future – how can we achieve optimal care and make health equity a reality for all people living with hemophilia A?


18:30-19:30

ROOM 3: Octapharma

Must-have Insights on prophylaxis in hemophilia A and von Willebrand disease

12:45-13:45

ROOM 1: Biomarin

Gene therapy in hemophilia: from decision to dosing


12:45-13:45

ROOM 2: CSL Behring

Optimizing the patient journey in von Willebrand disease: experiences and learnings as the navigator


12:45-13:45

ROOM 3: Sanofi

Redefining hemophilia: finding hemostatic balance within the evolving treatment landscape

*

The World Federation of Hemophilia does not endorse particular treatment products or manufacturers; any reference to a product name is not an endorsement by the WFH. The WFH is not a regulatory agency and cannot make recommendations relating to safety of manufacturing of specific treatment products. Some sessions may be accessible to healthcare professionals only.

NETWORKING OPPORTUNITIES

この国際的な集まりを通じて知識と喜びを融合させるため、あなたもぜひ仲間になってください。WFHのオープニングセレモニーが、マドリードの豊かな文化が織り込まれた魅惑的な背景の中で人脈を広げ、緊張を解き、素晴らしい時間を過ごす好機となることをお約束します。2024年WFH世界会議を学びの場とするのはもちろん、ひらめきとつながりの源にしていきましょう!

Please note that in adherence to Madrid regulations, cultural events and entertainment at social gatherings organized by the host (WFH) are not permitted during the WFH 2024 World Congress. We appreciate your understanding and eagerly anticipate providing you with a seamless and enriching, knowledge-focused experience at this year’s Congress. Your participation is highly valued, and we look forward to making this event as informative and enjoyable as possible.

PRESENTATION THEATRE

Stop by the presentation theatre in Exhibit Hall 9 for a number of exciting sessions.

ABSTRACTS AND POSTERS

View the 2024 ePoster gallery now.

The regular and late-breaking abstract submission periods have ended. We thank all authors who submitted their research to the WFH 2024 World Congress.

Presenting authors who submitted their abstract during our regular submission period have already been notified about their acceptance status. Late breaking abstract submitters will be notified by March 15, 2024.

The WFH would like to thank our expert Abstract Review Committee for the time they took to review the 2024 abstract submissions. Their contribution in the impartial review process has allowed the WFH to maintain a high level of quality for the WFH 2024 World Congress program.

There will be as many as 45 free paper oral presentations and 75 moderated poster presentations, in addition to the 300+ posters displayed in our in-person and virtual poster galleries. For more information on our free paper and moderated poster sessions, please visit our full program.

Poster and presentation guidelines

Presenting authors should download and carefully read the following guidelines prior to preparing and submitting their poster and/or presentation.

Free paper presentation

Click on the button below to access the free paper presentation guidelines.

Moderated poster presentation

Click on the button below to access the moderated poster presentation guidelines.

Poster submission guidelines

Click on the button below to access the poster submission guidelines.

演題登録方法

登録される前に、必ず演題登録ガイドラインをよくお読みください。

演題登録方法

ステップ1: プロフィールを作成してログインし、演題スコアカード(Abstract Scorecard)にアクセスします。

ステップ2: 演題登録に必要な手順をすべて行います。

ステップ3: すべて完了したら、登録する(submit)をクリックします。

登録した演題を編集する

登録期限の2024年02月14日までは、登録した演題を編集することができます。

ステップ1: 演題を編集するには、演題スコアカード(Abstract Scorecard)サイトにログインしてご自身の演題にアクセスします。ここで、すでに入力済みのタスクにアクセスし、更新することによって演題を編集することができます。

重要な注意事項:

演題は、このオンラインシステム以外では登録できません。 郵送や電子メールで提出されたものは審査対象外となります。
適切に登録されたもののみ審査対象となります。不備がある場合は自動的に不受理となります。

Poster networking event

When: Monday, April 22 – 19:30-20:30
Where: Poster gallery within the exhibit hall


Learn more about the work and research showcased in our poster gallery, from the authors themselves! Join us for an evening of sharing information, fostering connections, sparking conversations, and inspiring collaboration within the bleeding disorders community.

演題登録

さあ、今すぐにあなたの成果物を登録して、数多くの一流の専門家に加わり出血性疾患患者の治療やケアにおける最新の進歩について話し合いましょう。

ご不明な点がありましたら、[email protected] へご連絡ください。

2024年WFH世界会議の演題査読委員会は、幅広い専門分野と科学的手法を持つ者から構成される優れた専門家集団です。

Prem Roop Alva

Jan Astermark

Cindy Bailey

Branislav Bajkin

Marlène Beijlevelt

Erik Berntorp

Greig Blamey

Megan Brown

Tyler Buckner

Patricia Cabré

Manuel Carcao

Alessandro Casini

Giancarlo Castaman

Nathan Connell

Elvira Correa

Susan Cutter

Emmanuel Favaloro

Antonio Gavrilovski

Gaby Golan

Emna Gouider

Cesar Haddad

Cathy Harrison

Cedric Hermans

Shannon Jackson

Paula James

Christine Kempton

Kate Khair

Steve Kitchen

Christoph Königs

Barbara Konkle

Roshni Kulkarni

Riitta Lassila

Michelle Lavin

David Lillicrap

Johnny Mahlangu

Mike Makris

Tadashi Matsushita

Paul McLaughlin

Wolfgang Miesbach

Richa Mohan

Lochana Nanayakkara

Margareth Ozelo

David Page

Gianluigi Pasta

Glenn Pierce

Steve Pipe

Debra Pollard

Margaret Rand

Hortensia de la Corte Rodriguez

Dawn Rotellini

Thomas Sannié

Veena Selvaratnam

Roger Schutgens

Midori Shima

Robert Sidonio

Mauricio Silva

Mark Skinner

Penni Jo Smith

Alok Srivastava

Jeff Stonebraker

Sophie Susen

Merel Timmer

Graeme Ting

Pierre Toulon

Nanda Uitslager

Angela Weyand

Sarah Whitaker

Deadline to submit poster: April 8, 2024
Deadline to submit PowerPoint slides for free paper presentations: April 17, 2024

重要な日付
演題募集開始日 2023年9月15日
演題登録期限 2023年11月30日午後11:59(米国東部時間)
著者への通知 2023年12月22日
発表者の登録期限 2024年1月31日
LATE-BREAKING ABSTRACT(演題募集締め切り以降に進展があった研究)
Late-breaking abstract募集開始日 2024年1月17日
Late-breaking abstract登録期限 2024年2月14日午後11:59(米国東部時間)
著者への通知 2024年3月15日
発表者の登録期限 2024年3月31日

Presenting authors should download and carefully read the following guidelines prior to preparing and submitting their poster and/or presentation:

Abstract Public Release (Embargo) Dates and Times

Late-breaking abstracts (LBAs) will be publicly released throughout the WFH 2024 World Congress. The complete embargo dates and public release schedule for LBAs is detailed below.

All other abstracts, including those submitted during the late-breaking submission time period but not selected as late-breaking abstracts, will be publicly released at 9:00 a.m. CEST on April 21, 2024, and available online.

ABSTRACTS
Abstracts published in the Haemophilia journal Embargo will lift
9:00 a.m. CEST on April 21, 2024
LATE-BREAKING ABSTRACTS
Free paper presentation date Embargo will lift
Monday, April 22 9:00 a.m. CEST on April 22, 2024
Tuesday, April 23 9:00 a.m. CEST on April 23, 2024
Wednesday, April 24 9:00 a.m. CEST on April 24, 2024

この会議は、2024年に開催される出血性疾患に関する国際イベントでは最も包括的なものとなります。発表者は世界中のトップクラスの専門家や研究者と成果物を共有することができます。

選出された演題は以下の対象となります。

バーチャルポスターギャラリーでの表示–オンラインで60日間閲覧可能
Haemophilia誌(WFHの公式刊行物)への掲載
一般演題セッションでの口頭発表
座長の進行によるポスターセッションにおけるライトニングラウンド発表(Lightning round presentation:短い時間制限が設けられたプレゼンテーション)
ポスターでのネットワーキングイベントおよび休憩時間中の印刷したポスターを使用した発表
口頭発表の最優秀者に贈られるChristine Lee Young Researcher Award(Christine Lee若手研究者賞)
ポスター発表の最優秀者に贈られるChristine Lee Young Researcher Award(Christine Lee若手研究者賞)– 2024年初!
優れた演題に贈られるトラベル賞 – 2024年初!

マドリードでお会いできることを楽しみにしています!

重要な日付
演題募集開始日 2023年9月15日
演題登録期限 2023年11月30日午後11:59(米国東部時間)
著者への通知 2023年12月22日
発表者の登録期限 2024年1月31日
LATE-BREAKING ABSTRACT(演題募集締め切り以降に進展があった研究)
Late-breaking abstract募集開始日 2024年1月17日
Late-breaking abstract登録期限 2024年2月14日午後11:59(米国東部時間)
著者への通知 2024年3月15日
発表者の登録期限 2024年3月31日

演題をオンラインで提出する前に、以下のガイドラインをダウンロードしてよくお読みください。

ず演題登録ガイドライン

Late-breaking abstract(LBA)の登録期間は、20241172024214です。

Late-breaking abstractは、日常診療に変化をもたらす最新の進歩について記述してあり、診療を変える新しい研究に光を当てているものとします。選考プロセスでは、独創的でほかに例を見ないデータが使用され、世界会議で発表されたことがない演題を優遇します。いずれの場合も、通常の演題登録期限以降に十分な結果を得られたものを対象とします。

Abstract Public Release (Embargo) Dates and Times

Late-breaking abstracts (LBAs) will be publicly released throughout the WFH 2024 World Congress. The complete embargo dates and public release schedule for LBAs is detailed below.

All other abstracts, including those submitted during the late-breaking submission time period but not selected as late-breaking abstracts, will be publicly released at 9:00 a.m. CEST on April 21, 2024, and available online.

ABSTRACTS
Abstracts published in the Haemophilia journal Embargo will lift
9:00 a.m. CEST on April 21, 2024
LATE-BREAKING ABSTRACTS
Free paper presentation date Embargo will lift
Monday, April 22 9:00 a.m. CEST on April 22, 2024
Tuesday, April 23 9:00 a.m. CEST on April 23, 2024
Wednesday, April 24 9:00 a.m. CEST on April 24, 2024

2024年WFH世界会議の演題査読委員会は、幅広い専門分野と科学的手法を持つ者から構成される優れた専門家集団です。

HAEMOPHILIA SUPPLEMENTS

WFH 2024 State of the Art Book

This peer reviewed supplement reflects the best clinical practice advice and expert opinion within the various subspecialties of bleeding disorders and related fields that will be presented in the scientific program of the WFH 2024 World Congress.


WFH 2024 Book of Abstracts

Plan your calendar for free paper sessions, moderated poster presentations, and a comprehensive poster gallery, all showcasing the research and work presented on the abstracts of the WFH 2024 World Congress.

演題に与えられる賞

Christine Lee Young Researcher Award (Christine Lee若手研究者賞)

Christine Lee Young Researcher Award(旧名称はChristine Lee Haemophilia Journal Award[Christine Lee Haemophilia誌賞])は、世界血友病連盟(WFH)とWiley社が2012年に創設した賞で、血友病やその他関連する出血性疾患と関係のある学問分野において、高評価を得た登録演題の筆頭著者および発表者である最も優秀な若手研究者(大学院生や博士研究員)として認められた者に贈られます。


口頭発表最優秀賞

賞金3,000米ドルと、Haemophilia誌のオンライン個人購読3年間が贈られます。


ポスター発表最優秀賞

賞金1,000米ドルと、Haemophilia誌のオンライン個人購読3年間が贈られます。

選考対象者

選考委員会(Haemophilia誌編集者と編集委員会のWFH代表者など)が、2024年WFH世界会議で最優秀演題を選出します。受賞者は各賞につき1名とします。

演題登録時に40歳未満の若手研究者であること。著者が複数の場合、筆頭著者および発表者は演題登録時に40歳未満である必要があります。

優れた演題に贈られるトラベル賞

WFHは、2024年WFH世界会議に登録された演題のうち高評価を得た5演題に対し、それぞれ1,000米ドルの補助金を提供します。

トラベル賞の選考対象になることを希望される場合は、演題登録時にその旨をお知らせください。できる限り多くの参加者がWFHトラベル賞の恩恵を受けられるよう、別の資金源を利用できる方は、そちらを優先していただきますようお願いいたします。

ABSTRACTS FAQ

Q
How long should my abstract be?
A

Your abstract should be no longer than 350 words. This does not include the author’s details, titles, tables, and graphs.

Q
Can I include tables/graphs in my abstract?
A

A maximum of two tables and/or graphs can be included in an abstract. Please make sure to add headings to each of the tables and/or graphs, and reference them within the abstract. Please do not include the author list on the figure/table you are uploading, as we operate by blind review.

Q
How many abstracts can I submit?
A

There is no limit on the number of abstracts a single author can submit.

Q
How many abstracts can I present?
A

Each presenting author may present a maximum of two abstracts at Congress. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.

Q
Can I submit my abstract by email?
A

No. Abstracts should only be submitted through the online submission system. Abstracts sent via email will not be accepted.

Q
Can I submit an abstract in a language other than English?
A

No. Abstracts will only be accepted in written English. Abstracts submitted in any language other than English will be automatically rejected.

Q
How many authors can be listed for each submission?
A

A maximum of 20 authors is permitted on each abstract.

Q
Can I edit/make changes to my abstract?
A

Revisions can be made until the late-breaking abstract submission deadline: February 14, 2024 at 11:59pm ET. To ensure the integrity of the review process, no revisions will be allowed after the late-breaking abstract submission deadline.

Q
Can I submit a trial-in-progress abstract?
A

Yes. The WFH is accepting trials-in-progress abstracts. Please consult the abstract submission guidelines for details.

Q
Can an administrator/third party submit an abstract on behalf of the authors?
A

Yes. However, note that if the abstract is accepted, all subsequent notifications and correspondence will be addressed to the presenting author.

Q
When will I know if my abstract has been accepted?
A

You will be notified if your abstract has been accepted no later than December 22, 2023. You will be notified if your late-breaking abstract has been accepted no later than March 15, 2024.

Q
Do I need to register to attend the World Congress?
A

Yes. All regular abstract presenting authors must register to attend the WFH 2024 World Congress by January 31, 2024. All LBA presenting authors must register to attend the WFH World Congress by March 31, 2024. After this date, presenting authors who have not registered and paid their registration fees will be excluded from the program as well as from the Haemophilia journal publication. Registration fees will not be waived.

Q
Can I present virtually?
A

No. The 2024 World Congress will take place in-person only. Presenting authors will therefore be required to be onsite in Madrid, Spain.

Q
When will my accepted abstract be published?
A

Abstracts selected for publication will be made available in the online Haemophilia journal publication by April 21, 2024. The publication will be available on the Wiley website, the WFH 2024 World Congress website, and the Congress mobile app. Late-breaking abstracts selected for publication will be made available after Congress. More information to come.

Q
Will the WFH be accepting late-breaking abstracts?
A

Yes. The call for late-breaking abstracts will open on January 17, 2024 and will close on February 14, 2024.

Additional questions? Please contact us at [email protected].

Share on:

*  

Enter your email to join the WFH newsletter and stay on top of important developments in the global bleeding disorders community.

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.

Hemophilia Alliance

Recognizing that training women leaders ensures the diversity our community need to thrive; the Hemophilia Alliance has been a longtime supporter of the Susan Skinner Memorial Fund. They deepened their engagement with the global community through the establishment of the Travel Grant Program, which allows US-based multidisciplinary healthcare professionals the opportunity to attend WFH global training workshops. The wealth of experience and perspective attendees bring back home to their communities helps patients across the country. Their patience and support as we grappled with changing norms in these challenging times gave us the flexibility to meet our community’s needs with revamped programming.

Israel - Tel Hashomer

Year of IHTC designation: 1993

National Hemophilia Center, Tel Hashomer
Sheba Medical Center

Areas of Specialty

  • Adult and pediatric hematology
  • Orthopedic surgery
  • Nursing
  • Physiotherapy
  • Dental care
  • Laboratory diagnosis (not genetics)
  • Psychology

South Africa - Johannesburg

Year of IHTC designation: 2016

Haemophilia Comprehensive Care Centre
Charlotte Maxeke Johannesburg Academic Hospital

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Physiotherapy

Singapore - Singapore

Year of IHTC designation: 2002

Singapore General Hospital Haemophilia Treatment Clinic

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis
  • Nursing
  • Dental care
  • Orthopedic care (no surgeries)
  • Physiotherapy
  • Psychology

Senegal - Dakar

Year of IHTC designation: 2016

Centre International de Traitement de l’Hémophilie (CITH) de Dakar
Centre National de Transfusion Sanguin (CNTS)

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Blood banking
  • Physiotherapy

Russia - Moscow and St. Petersburg

Year of IHTC designation: 2010

National Medical Research Center of Hematology of the Russian Academy of Medical Sciences

Areas of Specialty

  • Adult hematology
  • Nursing
  • Orthopedic surgery

Netherlands - Utrecht

Year of IHTC designation: 1996

Van Creveldkliniek
University Medical Centre Utrecht

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hematology
  • Nursing
  • Orthopedic care and surgery
  • Physiotherapy/Occupational therapy

Japan - Nara

Year of IHTC designation: 1998

Nara Hemophilia Centre
Nara Medical University

Areas of Specialty

  • Adult and pediatric hematology
  • Orthopedic care and surgery
  • Laboratory diagnosis and Molecular genetics
  • Physiotherapy

Italy - Milan

Year of IHTC designation: 1972

Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Dental care
  • Blood banking
  • Orthopedic care and surgery
  • Physiotherapy
  • Diagnostic assessment of platelet functional defects

India - Mumbai

Year of IHTC designation: 2000

National Institute of Immunohaematology (ICMR) and KEM Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Dental care
  • Orthopedic care
  • Physiotherapy

India - Vellore

Year of IHTC designation: 2000

Christian Medical College, Vellore

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics with antenatal diagnosis
  • Nursing
  • Musculoskeletal management – physical and occupational therapy with physiatry
  • Orthopedic care and surgery
  • Blood banking
  • Dental care
  • Psychology/Social services
  • Antenatal diagnosis

Sweden - Malmö

Year of IHTC designation: 1976

Malmö Centre for Thrombosis and Haemostasis
Department for Hematology and Coagulation Disorders, Skåne University Hospital
Skåne University Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and genetics
  • Nursing
  • Dental care and surgery
  • Orthopedic care and surgery
  • Blood banking (on request)

France - Paris

Year of IHTC designation: 1972

Paris Haemophilia Centre (Necker (N) and Kremlin Bicetre (KB) Hospitals)

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Dental care
  • Orthopedic care and surgery
  • Psychology and Social services

Egypt - Cairo

Year of IHTC designation: 2015

Shabrawishi Hospital, Egyptian Society of Hemophilia, and Cairo University

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Molecular genetics
  • Blood banking
  • Physiotherapy

Canada - Toronto

Year of IHTC designation: 2018

University of Toronto Hemophilia Centres
St. Michael’s Hospital

Areas of Specialty

  • Adult hematology services
  • Pediatric hematology services
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

Brazil - Campinas, SP

Year of IHTC designation: 2008

Hemocentro – “Unidade de Hemofilia Cláudio Luiz Pizzigatti Corrêa”
Hemocentro Unicamp, University of Campinas

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and molecular genetics
  • Nursing
  • Dentistry
  • Physiotherapy

Belgium - Brussels

Year of IHTC designation: 2013

Haemostasis and Thrombosis Unit
Division of Haematology
Cliniques universitaires Saint-Luc

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis
  • Orthopedic care and surgery

Belgium - Leuven

Year of IHTC designation: 1972

Hemofiliecentrum Leuven, University of Leuven

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis (not genetics)
  • Nursing
  • Psychology
  • Social services
  • Orthopedic care and surgery

Austria - Vienna

Year of IHTC designation: 1972

Medical University of Vienna
Department of Medicine I
Clinical Division of Hematology and Hemostaseology

Areas of Specialty

  • Adult hematology

Australia - Melbourne

Year of IHTC designation: 2005

Ronald Sawers Haemophilia Centre

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Orthopedic care and surgery
  • Nursing
  • Dental care
  • Blood banking
  • Psychology
  • Social work

Argentina - Buenos Aires

Year of IHTC designation: 1974

Instituto Asistencial “Dr. Alfredo Pavlovsky”
(Fundación de la Hemofilia)

Instituto De Investigaciones Hematológicas “Dr. Mariano R. Castex” (IIHEMA
(Academia Nacional de Medicina)

Areas of Specialty

  • Adult and pediatric hematology
  • Physiotherapy
  • Dental care
  • Orthopaedic care and surgery
  • Laboratory diagnosis and genetic diagnosis
  • Nursing
  • Psychology
  • Social services

Spain - Madrid

Year of IHTC designation: 2018

Hospital Universitario La Paz

Areas of Specialty

  • Adult and pediatric hematology
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

Spain - Valencia

Year of IHTC designation: 1997

Haemostasis and Thrombosis Unit
Haematology Service, University and Polytechnic Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Nursing
  • Orthopedic care and surgery
  • Physiotherapy
  • Blood banking
  • Psychology and Social services

Thailand - Bangkok

Year of IHTC designation: 1984

International Hemophilia Training Center – Bangkok
Ramathibodi Hospital
Mahidol University

Areas of Specialty

  • Adult and pediatric hemostasis
  • Molecular genetics
  • Nursing
  • Dental care and surgery
  • Orthopedic care and surgery
  • Physiotherapy
  • Blood banking
  • Psychology and social services

Hemophilia of Georgia

Hemophilia of Georgia has stood with us for over three decades, playing an early role in distributing donated factor via the WFH Humanitarian Aid program. Our relationship has deepened over the years as they continued to support this program and came on board as a founding Chapter Challenge champion in 2016. Their belief in educating future leaders is clear in their investment in the Youth Leadership Workshops, which has led to the training of over 50 young adults. They also support workshops devoted to educating providers and patient leaders on how to collect and use data to advocate for better patient care. Their staff generously volunteer their time as trainers and as well as serving on various committees.

WFH President's Award - Recipients

National Bleeding Disorders Foundation

The National Bleeding Disorders Foundation helps advance our mission on several fronts. They inspire others to follow their lead as a founding champion of the NHF Chapter Challenge. Their commitment to equality of access is demonstrated in their support of the Cornerstone Initiative, which lays the foundation for care in the world's most underserved regions, as well as programs that aim to raise awareness and improve care of women with bleeding disorders and those with von Willebrand disease. We also benefit from their steadfast engagement with various programs including the WFH Twinning Program and their individual leaders’ contribution to our leadership and committees.

Legacy Gift